HIGHLIGHTS
- who: Wei Yu et al. from the Medicine, Beijing University have published the paper: Therapeutic potential of paeoniflorin in atherosclerosis: A cellular action and mechanism-based perspective, in the Journal: (JOURNAL)
- how: Several pharmacokinetic parameters were measured in a clinical study in Chinese volunteers and data showed that the mean half-life (tu00bd) after a single intravenous injection of 18.3 mg 35.8 mg or 54.1 mg of paeoniflorin was 1.9 h 1.9 h or 1.8 h in males and females respectively. Their results showed that paeoniflorin significantly reduced the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.